about
Hidden association of Cowden syndrome, PTEN mutation and meningioma frequencyLuciferase fragment complementation imaging in preclinical cancer studiesGenomics of chromophobe renal cell carcinoma: implications from a rare tumor for pan-cancer studiesNon-coding RNAs in lung cancerThe emerging roles of GPRC5A in diseasesThe "virgin birth", polyploidy, and the origin of cancerSelective glucocorticoid receptor-activating adjuvant therapy in cancer treatmentsInhibition of 19S proteasome-associated deubiquitinases by metal-containing compoundsCross Talk between Two Antioxidant Systems, Thioredoxin and DJ-1: Consequences for CancerHER2 and uPAR cooperativity contribute to metastatic phenotype of HER2-positive breast cancerAID/APOBEC deaminases and cancerThe migration ability of stem cells can explain the existence of cancer of unknown primary site. Rethinking metastasisHigh and low dose radiation effects on mammary adenocarcinoma cells - an epigenetic connectionDrug conjugation to hyaluronan widens therapeutic indications for ovarian cancerNecrosis, and then stress induced necrosis-like cell death, but not apoptosis, should be the preferred cell death mode for chemotherapy: clearance of a few misconceptionsHigh-frequency ultrasound detection of cell death: Spectral differentiation of different forms of cell death in vitroQuantitative ultrasound imaging of therapy response in bladder cancer in vivo.High-frequency ultrasound analysis of post-mitotic arrest cell death.Breast tumor response to ultrasound mediated excitation of microbubbles and radiation therapy in vivo.Quantitative evaluation of cell death response in vitro and in vivo using conventional-frequency ultrasoundLow intensity focused ultrasound (LOFU) modulates unfolded protein response and sensitizes prostate cancer to 17AAG.Recurrent ZFX mutations in human sporadic parathyroid adenomasAnalysis and interpretation of transcriptomic data obtained from extended Warburg effect genes in patients with clear cell renal cell carcinoma.NY-ESO-1 expression in DCIS: A new predictor of good prognosis.Theranostic Profiling for Actionable Aberrations in Advanced High Risk Osteosarcoma with Aggressive Biology Reveals High Molecular Diversity: The Human Fingerprint HypothesisRapid and efficient transfer of the T cell aging marker CD57 from glioblastoma stem cells to CAR T cellsNLRs: Sentinels of innate immunity or cancer culprits?Adaptors for disorders of the brain? The cancer signaling proteins NEDD9, CASS4, and PTK2B in Alzheimer's disease.Glycolysis, tumor metabolism, cancer growth and dissemination. A new pH-based etiopathogenic perspective and therapeutic approach to an old cancer questionGeneration of a syngeneic orthotopic transplant model of prostate cancer metastasisResistance to c-Kit inhibitors in melanoma: insights for future therapiesPerturbations of the endocannabinoid system in mantle cell lymphoma: correlations to clinical and pathological features.Kallikrein-related peptidase 5 induces miRNA-mediated anti-oncogenic pathways in breast cancer.Identification of a class of human cancer germline genes with transcriptional silencing refractory to the hypomethylating drug 5-aza-2'-deoxycytidine.Low dose irradiation profoundly affects transcriptome and microRNAme in rat mammary gland tissues.MDA-9/Syntenin regulates differentiation and angiogenesis programs in head and neck squamous cell carcinomaAntagonistic analogs of growth hormone-releasing hormone increase the efficacy of treatment of triple negative breast cancer in nude mice with doxorubicin; A preclinical studyA framework for genomic biomarker actionability and its use in clinical decision makingAchilles' heel of triple negative cancerPredictive biomarkers for dasatinib treatment in melanoma.
P1433
Q26739125-964E4BC4-D938-4D34-8973-059FA4E0119BQ26851635-AA231647-32BB-4159-9899-FB3F5470E56BQ26851787-91870C1C-51DB-41B8-8FEE-3361A9923565Q26866521-FE003E1D-C811-4BC7-9770-008698951977Q27020926-C9A89F97-71FF-4044-86A1-3767483EF47AQ27024916-5EA83226-9B41-42F8-920E-D02B8AB3B92FQ28078896-2C23C7A0-7153-4AF0-8FF2-0D809DA36113Q28082497-F4B0438A-1940-4254-988B-5C5BD96A00CCQ28083118-6FE52726-863A-4261-9DF0-E7C7BEFEF4DCQ28085413-71E3DF25-4833-4349-9308-A3E9096BD67FQ28085553-F70B3F9A-C882-4BB5-B9A4-0A036478EF66Q28263853-A8C4BCA1-7122-4F73-922F-58A82E664A4EQ28394677-1FB97079-1B06-4283-B38A-1640FA61B18FQ28648402-C08F293E-73D6-4679-B434-EBDE234BFDCFQ28652643-A9F75B33-B29F-41D3-9E9E-E8E12C0188F3Q30366364-ACB644F1-91A2-4611-A886-B459A7675073Q30383168-EE26A16A-A549-45DA-A894-AD720F42427DQ30383171-D276F7E3-9B61-4BDB-931B-AA048F0A8C14Q30383174-FC1BAE13-3DCE-4E78-83F6-6A3A3002FE85Q30402219-24FABC02-6749-43DE-87CB-0C12DDDD1E47Q30420792-2BA959CA-766E-4CEC-927F-718A78461545Q30420795-B79969DB-4BE1-4E64-B627-33E9F32757EAQ30928926-40EA0B91-3EA1-486A-9BA6-09013D212362Q33718676-10279370-A2B8-4AFD-9148-F0F4BE253B60Q34025926-31823348-F4E5-4AAE-8074-6C7B0F43CE70Q34044302-5F4A9734-D951-4839-8C11-341E9422062BQ34458453-A589DD7D-BC8C-4615-89ED-771F32A01BF4Q34458459-C24685C5-2AA1-42B7-ABBF-773BFBD013EBQ34459681-4135542A-FE5A-4517-B3A4-2CEC84135309Q34626533-E4BC90A1-561B-429F-BC6A-F9B9ED87F842Q34667532-DFDEFCB4-3DF4-4A62-99AB-4DB256498890Q34667539-276ABFC2-9773-4445-AC67-0AB5DCA6E5C0Q34781039-C8CC88E5-1DD0-4CB3-8B52-9B8780B71E19Q34781073-1E5F9159-AE0A-4F38-8694-12E96ABD2D82Q34781086-C8D31C2A-F334-4ABD-9D20-F49DFCB93DF0Q34781101-F34A902E-2BF1-4B59-A0F1-22481857E0E8Q34781112-F6140F95-83BF-45C2-A786-03B7A0DA4C4FQ34781122-EB264AAD-01BD-4B33-9EA9-9D4009222FDAQ34781145-6F41463B-60C8-42F6-BBF8-5ED92CE22400Q34781153-DF9F6542-434E-4075-A8E5-0EAA951165D1
P1433
description
journal
@en
revista científica
@es
wetenschappelijk tijdschrift
@nl
wissenschaftliche Fachzeitschrift
@de
name
Oncoscience
@ast
Oncoscience
@en
Oncoscience
@es
Oncoscience
@nl
type
label
Oncoscience
@ast
Oncoscience
@en
Oncoscience
@es
Oncoscience
@nl
prefLabel
Oncoscience
@ast
Oncoscience
@en
Oncoscience
@es
Oncoscience
@nl
P3181
P1055
P1156
21100446518
P1476
Oncoscience
@en